Search research articles
Contact Us
Filters
Showing results (81-90 of 176) with videos related to
Page
of 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2004
Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015)
Susan M Blaney, Mark Bernstein, Kathleen Neville, et al.
Neurology
|
December 18, 2016
Second monotherapy in childhood absence epilepsy
Avital Cnaan, Shlomo Shinnar, Ravindra Arya, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 18, 2011
A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology Group
Sylvain Baruchel, Alberto Pappo, Mark Krailo, et al.
Pediatric Blood & Cancer
|
September 25, 2004
Amifostine for children with medulloblastoma treated with cisplatin-based chemotherapy
Michael J Fisher, Beverly J Lange, Michael N Needle, et al.
Pediatric Blood & Cancer
|
June 30, 2012
Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: a Children's Oncology Group study
Anne B Warwick, Suman Malempati, Mark Krailo, et al.
Anesthesia and Analgesia
|
April 27, 2010
Population pharmacokinetics of dexmedetomidine in infants after open heart surgery
Felice Su, Susan C Nicolson, Marc R Gastonguay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2010
Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a Children's Oncology Group Phase I Consortium report
Stacey L Berg, Mitchell S Cairo, Heidi Russell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2007
Phase I Trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a Children's Oncology Group Study
Susan R Rheingold, Michael D Hogarty, Susan M Blaney, et al.
The New England Journal of Medicine
|
March 5, 2010
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy
Tracy A Glauser, Avital Cnaan, Shlomo Shinnar, et al.
Pediatric Blood & Cancer
|
April 11, 2019
Unintended consequences of evolution of the Common Terminology Criteria for Adverse Events
Tamara P Miller, Brian T Fisher, Kelly D Getz, et al.
Page
of 18
Search research articles
Search
Showing results (81-90 of 176) with videos related to
Sort By:
Page
of 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2004
Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015)
Susan M Blaney, Mark Bernstein, Kathleen Neville, et al.
Neurology
|
December 18, 2016
Second monotherapy in childhood absence epilepsy
Avital Cnaan, Shlomo Shinnar, Ravindra Arya, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 18, 2011
A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology Group
Sylvain Baruchel, Alberto Pappo, Mark Krailo, et al.
Pediatric Blood & Cancer
|
September 25, 2004
Amifostine for children with medulloblastoma treated with cisplatin-based chemotherapy
Michael J Fisher, Beverly J Lange, Michael N Needle, et al.
Pediatric Blood & Cancer
|
June 30, 2012
Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: a Children's Oncology Group study
Anne B Warwick, Suman Malempati, Mark Krailo, et al.
Anesthesia and Analgesia
|
April 27, 2010
Population pharmacokinetics of dexmedetomidine in infants after open heart surgery
Felice Su, Susan C Nicolson, Marc R Gastonguay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2010
Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a Children's Oncology Group Phase I Consortium report
Stacey L Berg, Mitchell S Cairo, Heidi Russell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2007
Phase I Trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a Children's Oncology Group Study
Susan R Rheingold, Michael D Hogarty, Susan M Blaney, et al.
The New England Journal of Medicine
|
March 5, 2010
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy
Tracy A Glauser, Avital Cnaan, Shlomo Shinnar, et al.
Pediatric Blood & Cancer
|
April 11, 2019
Unintended consequences of evolution of the Common Terminology Criteria for Adverse Events
Tamara P Miller, Brian T Fisher, Kelly D Getz, et al.
Page
of 18